Delivery Order SPE2DB20D3103-SPE2DB26FL5D9
- Not listed
- The Defense Logistics Agency awarded a $2,615.88 delivery order to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (2-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,240.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (two-unit package) on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected to deliver this emergency...
- The Defense Logistics Agency awarded a delivery order valued at $2,841.52 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack units) with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.00 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,143.28 for Narcan 4 mg nasal spray (2-count units) on June 18, 2025, with completion targeted for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete fulfillment under AmerisourceBergen's broader pharmaceutical supply infrastructure...
- The Defense Logistics Agency awarded a delivery order valued at $1,594.44 to AmerisourceBergen Drug Corp for Narcan 4 mg nasal spray (2-pack units) on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's established Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $6,947.25 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (two-pack units) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Narcan (naloxone) is a critical emergency medication used to rapidly reverse opioid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units) with a ceiling value of $1,667.87. This firm fixed price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis, reflecting...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Narcan 4 mg nasal spray (two-count packages) with a ceiling value of $3,574.16. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $2,449.20 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Narcan 4 mg nasal spray (2-pack units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL5D9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,938.89 to AmerisourceBergen Drug Corp for the supply of Narcan 4 mg nasal spray (2-pack units) on November 5, 2025, with completion targeted for November 6, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor specializing in pharmaceutical products and medical supplies for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products, specialty medications, vaccines, and medical supplies to support military healthcare programs worldwide. The underlying contract structure demonstrates the contractor's established capability to meet federal procurement requirements through open competition and its significant role in supporting Defense Health Agency and U.S. Coast Guard healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 11/5/25 |